Communiqués ABL Diagnostics

Actions

ABLD

FR001400AHX6

Marché Fermé - Euronext Paris Autres places de cotation 11:30:50 31/05/2024			Varia. 5j.	Varia. 1 janv.
3,04 ^EUR	-.--%		-.--%	-68,66 %

2023	ABL Diagnostics Société anonyme publie ses résultats pour le semestre clos le 30 juin 2023	CI
2023	ABL Diagnostics Société anonyme publie ses résultats pour l'exercice clos le 31 décembre 2022	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ABL Diagnostics : Retard dans la publication des comptes annuels 2023	29/05	BU
ABL Diagnostics and Laborama officially appointed to offer NGS genotyping solutions to the National Laboratory for Public Health (NLPH) in Lithuania.	13/05	AQ
ABL DIAGNOSTICS : MISE EN PLACE D’UN CONTRAT DE LIQUIDITE AVEC ALLINVEST SECURITIES	23/04	BU
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.	17/04	AQ
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA	16/04	AQ
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.	18/03	AQ
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)	04/03	AQ
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA	28/02	AQ
ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.	28/02	AQ
AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA	20/02	AQ
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.	18/01	AQ
ABL DIAGNOSTICS INTRODUCING CRISPRCHEK - A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY	18/12	AQ
ABL Diagnostics releases new applications for respiratory viruses including Influenza, RSV and SARS-CoV-2	06/12	AQ
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	30/11	AQ
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	24/11	AQ
ABL Diagnostics : Document AMF CP. 2023DD925593	01/09/23	PU
Roche Diagnostics (Pty) Ltd and ABL Diagnostics enter into an Exclusive Distribution Agreement in South Africa	27/03/23	AQ
ABL Diagnostics : Document AMF CP. 222C1869	19/07/22	PU
ABL Diagnostics : New Distribution Partnership in Ethiopia & Bolivia	09/06/22	PU
Etablissements Fauvet Girel S A : Modalités de mise à disposition des documents préparatoires à l'AG	01/03/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ABL Diagnostics

Actions

ABLD

FR001400AHX6

Communiqués

Filtres